K-numberK252558
Device nameLumify Diagnostic Ultrasound System
ApplicantPhilips Ultrasound, LLC
Product codeIYN
Device classClass II
Decision dateMay 5, 2026
DecisionSubstantially Equivalent
Regulation892.1550
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Lumify Diagnostic Ultrasound System is a portable, software-controlled medical device that acquires and displays ultrasound data in B-mode (2D), Pulsed Wave Doppler, Color Doppler, Combined (B+Color), and M-modes. It is intended for diagnostic ultrasound imaging and fluid flow analysis across multiple clinical applications (fetal/obstetric, abdominal, cardiac, musculoskeletal, etc.) and is designed for use by qualified healthcare professionals in clinical environments.

Technological characteristics

The subject device adds a new software function called FAST Auto Assist, which provides real-time detection and labeling of abdominal organs and zones (LUQ, RUQ, Supra-Pubic) during FAST exams using artificial intelligence algorithms. The core system architecture remains unchanged; this is a software-only addition compatible with Android devices for adult patients (age ≥18). Only the S4-1 and C5-2 transducers work with the FAST Auto Assist feature.

Test standards cited

The device complies with FDA's ultrasound guidance document 'Marketing Clearance of Diagnostic Ultrasound Systems and Transducers' (February 21, 2023) and reference standards including IEC 60601-1 and IEC 60601-2-37. Non-clinical verification testing included requirements review, risk analysis, design reviews, and retrospective data analysis of artificial intelligence algorithm performance.

Substantial equivalence argument

The subject device is substantially equivalent to the primary predicate K223771 (Lumify Diagnostic Ultrasound System) because it maintains identical indications for use, intended use, modes of operation, user environment, and transducers (S4-1, C5-2), with no changes affecting device safety or effectiveness. The addition of FAST Auto Assist is a software-only feature that does not modify patient contact materials, hardware, or the underlying ultrasound acquisition and display functionality, and performance testing demonstrates high accuracy (86.0% overall) and safety comparable to predicate devices.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →